Noxopharm Limited 12 Name: Mr. Peter Marks Title: Non‐Executive Director and Deputy Chairman Experience and expertise: Peter has over 35 years’ experience in corporate advisory, investment banking and capital market’s activities. Over the course of his long career, he has specialised in capital raising IPOs, cross border and M&A transactions, corporate underwriting and venture capital transactions for companies based in Australia, the US and Israel. He has been involved in a broad range of transactions with a special focus in the life sciences, biotechnology, medical technology, high tech and more recently in the resources sectors. Peter has served as both an Executive as well as NonExecutive Director of a number of different companies listed on the ASX, Nasdaq and AIM markets. Peter holds a Bachelor of Economics, Bachelor of Laws and a Graduate Diploma in Commercial Law from Monash University, Australia. He also holds an MBA from the University of Edinburgh, Scotland. Other current directorships: Alterity Therapeutics Limited (ASX:ATH) - since 29 July 2005 (formerly known as Prana Biotechnology Limited and Iris metals (ASX:IR1) - since December 2020. Former directorships (last 3 years): Fluence Corporation Limited (ASX:FLC) - resigned 31 March 2020; Elsight Limited (ASX:ELS) - resigned 30 November, 2021 and Nyrada Limited (ASX:NYR) - resigned 1 August 2022. Interests in shares: 900,000 Interests in options: 66,667 Name: Mr. Boris Patkin Title: Non-Executive Director Experience and expertise: Boris brings comprehensive market knowledge, thorough research and years of experience in investment markets and Business Consulting. Boris’s experience lends itself to Financial and Investment advising but also as a business consultant to further enhance business opportunities in Medical technology and in sourcing other opportunities to enhance investments. Boris has worked extensively with Israeli companies to explore various opportunities in the Medical and disruptive technology space. Boris has developed an in-depth understanding of industry trends and gained valuable insight into domestic and international markets. Boris has specialised in reconstruction of Companies, Investments and International trade. He has extensive experience in developing and adding value to public listed companies, especially in the Medical, Resources and Retirement space. Boris has completed a Bachelor of Science (Industrial Chemistry). Currently a member of TASSA, MeSAFAA and an Authorised Representative Morgans Financial Ltd. Other current directorships: Non-Executive Chairman of Ausmon Resources Ltd - since 2014 Former directorships (last 3 years): N/A Interests in shares: 630,000 Interests in options: 310,000
RkJQdWJsaXNoZXIy MjE2NDg3